Autonomix receives Canadian patent for nerve therapy technology

Autonomix Medical Inc. has been granted a Canadian patent for its catheter-based transvascular intervention technology, covering systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall. The patent, No. 3,183,802, protects catheter-based tools designed to deploy probes through a lumen wall to access and treat nerves located outside the vessel.

The technology incorporates multi-site electrophysiological sensing capabilities, real-time feedback for adjusting stimulation or therapeutic energy delivery, and closed-loop control mechanisms. With 112 issued or pending patent applications worldwide, Autonomix Medical strengthens its intellectual property portfolio, which includes patents in the United States and Europe.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.